CompletedNot Applicable

Prevention of Hepatic Encephalopathy With Mobile Application Based Lactulose Titration

United States50 participantsStarted 2022-09-14

Plain-language summary

This study is being done to assess the safety and efficacy of using mobile application-based Bristol stool scale to titrate lactulose in prevention episodes of hepatic encephalopathy.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Ability to provide written, informed consent. * Currently taking lactulose daily for prevention of hepatic encephalopathy. Exclusion Criteria: * Recent change in dosing of opioid medication. * Previous Colorectal Surgery. * Active diarrheal illness. * Lack of smartphone or other smart device at home.

What they're measuring

Achievement of daily stool goal

Timeframe: 4 weeks

Trial details

NCT IDNCT05526404

SponsorMayo Clinic

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-07-08

View on ClinicalTrials.gov More Hepatic Encephalopathy trials